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ABSTRACT
SARS-CoV-2 RNA PERSISTENCE IN MUNICIPAL WASTEWATER TREATMENT
SYSTEMS PROVES WASTEWATER SURVEILLANCE IS AN EFFECTIVE TOOL FOR
MONITORING COVID-19 COMMUNITY HEALTH BURDENS
by
Melissa Schussman
The University of Wisconsin Milwaukee, 2022
Under the Supervision of Professor Sandra McLellan

Wastewater surveillance of SARS-CoV-2 is used worldwide to track COVID-19
infection trends. However, there is no standard method for SARS-CoV-2 measurement from
wastewater, and uncertainties of pre-analytical influences from the wastewater collection system
persist. This study builds upon the growing body of knowledge surrounding wastewater
surveillance and aims to understand how wastewater measurements relate to other public health
metrics, explain the influence of wastewater conveyance systems, and improve SARS-CoV-2
detection and quantification from wastewater.

Our laboratory has been part of the ongoing Wisconsin SARS-CoV-2 wastewater
surveillance program since August 2020, analyzing almost 4,000 samples to date. Through
various experiments, our findings demonstrated that monitoring variants in wastewater using RTddPCR can outperform clinical sequencing. Temperature was the only parameter that
significantly influenced SARS-CoV-2 decay in the wastewater matrix. Travel time, flow rate,
BOD, and TSS, did not significantly influence SARS-CoV-2 decay or detection. Additionally,
extracting RNA from primary settled solids improved detection sensitivity.
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Chapter 1: Literature Review and Background
1.1 Protection of human health

Looking at a broad evaluation of human health, The World Health Organization (WHO),
an agency of the United Nations, attests the human right to the highest attainable standard of
health [1]. The core elements to this right are requiring governments to take immediate steps
towards fulfilling the highest attainable standard of health when necessary and to not reduce
already-in-place protection of economic, social, and cultural rights. The core components of the
right to health are sufficiently available, accessible, and quality health care, goods, services, and
programs that are acceptable for all people requiring such resources [2]. WHO also helps enforce
the right to human health by developing global strategies against preventing and controlling
certain diseases of concern [3].

Focusing on human health in the United States (US), the US Department of Health and
Human Services (HHS) is a federal agency that was created to enhance the health and well-being
of all Americans by providing services and advances in medicine, public health, and social
science [4]. HHS has 11 operating divisions, one of which is the US Centers for Disease Control
and Prevention (CDC) to protect our country’s citizens from health and safety threats by
conducting experimentation, providing health information, and responding accordingly to health
threats [5].

1.2 COVID-19

The newly discovered coronavirus disease 2019 (COVID-19) disease is a highly
contagious disease that was submerged originally from a bat coronavirus. Coronaviruses are a

1

family of large enveloped positive-strand RNA viruses that infect vertebrates [6]. COVID-19
was first identified in Wuhan, China in December 2019, and has since spread worldwide, leading
to WHO declaring the COVID-19 outbreak as a pandemic on March 11, 2020 [7]. As of March
24, 2022, in the United States alone, over 81 million cases have been confirmed, with more than
1 million deaths resulting from COVID-19 [8]. This disease is spread through droplets or direct
contact with an infected individual [9]. Clinical presentations of COVID-19 range from
asymptomatic or mild symptoms to severe illness and mortality [10]. The incubation period of
COVID-19 ranges from 2 to 14 days, with an average of 5, after which, symptoms begin [11].
Characteristic symptoms of COVID-19 are similar to a common cold, or flu; including fever,
headache, and respiratory symptoms such as cough, difficulty breathing, sore throat, and
congestion [12]. But while infected patients typically present respiratory symptoms, studies have
shown that up to 35% of confirmed cases display gastrointestinal symptoms, such as diarrhea,
vomiting, and abdominal pain [5], [26], [28]. Due to asymptomatic and oligosymptomatic cases
in addition to limited testing availability, there is uncertainty surrounding the number of
diagnosed cases [13]. While current testing is being performed using nasopharyngeal and
oropharyngeal swabs, recent studies have also shown that stool samples can result in more
accurate detection of COVID-19 as it is shed in feces in concentrations up to 107 copies per
gram [23]. Positive fecal samples remained positive for an average of 12.5 days after respiratory
samples became negative, and in 1% of cases, infection would not have been diagnosed with
respiratory testing alone [25], [26].

1.2.1 SARS-CoV-2 RNA
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The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative
agent of COVID-19. It is an enveloped non-segmented positive-sense ribonucleic acid (RNA)
that belongs to the species Severe acute respiratory syndrome-related coronavirus and the genus
Betacoronavirus (Figure 1) [6]. Key distinguishing features of the SARS-CoV-2 genome that
make it so threatening to human health are a polybasic furin cleavage site that may increase
infectivity by enhancing cell to cell fusion without affecting viral entry, and O-linked glycans
that can cover epitopes, making it harder for the immune system to attack this foreign substance
[14].

Figure 1. 3-D model of the morphology of SARS-CoV-2 created by Gaslow Life Sciences [15].

1.3 Wastewater Surveillance

Wastewater surveillance is a public health tool involving extracting endogenous and
exogenous human biomarkers from a wastewater sample, then detecting, analyzing, and
interpreting specific compounds or molecules [15]. This method has been researched and applied
as a large population surveillance method for detecting and monitoring viral pathogens and
viruses [16], that can provide comprehensive health information on communities in real-time
[15], and unlike traditional clinical testing, one sample can be used to target numerous viruses or
pathogens. Wastewater surveillance provides an unbiased reflection of community health
accounting for a wide range of people who may often be missed or misrepresented by medical
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testing alone and can be used by health officials to rapidly assess emerging threats, and prepare
for pandemics [17].

1.3.1 Wastewater

Approximately 80% of US households are served by municipal wastewater collection
systems, permitting fecal waste to arrive at a wastewater treatment plant within just a few hours
[17]. This wastewater influent reflects an integrated profile of the human population microbiome
within the community contributing waste into the treatment system [18]. Wastewater has an
extremely multifaceted and dynamic composition, that varies depending on location, time of the
year, weather, and individual pollutants from industrial, urban, environmental, and residential
sources [19]. Sixty-five toxic and priority pollutants, among various others, are monitored in
wastewater effluent under the Code of Federal Regulations (CFR), but the true composition of
wastewater at any given time is unknown [19].

1.3.2 Methodological Considerations

Because wastewater is such a complex matrix, it can be challenging to get a sample that
contains enough concentration for target detection. There are peak times associated with higher
residential water usage such as mornings due to showers, and evenings due to washing machine,
or dishwasher use [20], [21]. In addition, environmental factors, such as a severe rain event, or
snowmelt can lead to an overdiluted sample. It is important to take these such events into
account when collecting samples. A measure used to assess possible dilution of a sample is to
test each sample for human fecal indicators, such as Pepper Mild Mottle Virus (PMMoV) which
is an extremely common RNA virus found in human fecal waste as a result of eating peppers
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[22]. Using a human-specific fecal marker in the sample processing can better quantify the
number of people contributing to a sewershed, can be used as a comparative measure between
samples over time, and can help account for viral losses throughout the wastewater conveyance
or laboratory processes [23].

In addition to sample dilution, there are many contaminants that can interfere with the
target compound in wastewater analysis. The abundance of biological and chemical substances
in wastewater makes it harder to successfully extract the target biomarker and may cause
inhibition of detection even when successfully extracting a specific biomarker [15]. To avoid
undetected inhibition, an inhibition control may be necessary. This involves spiking polymerase
chain reaction (PCR) aliquots with a non-native molecular target, and confirming this target can
be detected when the plate is read [24]. It may also be necessary to use blind matrix spikes,
which involve spiking wastewater samples with a surrogate virus to measure viral RNA recovery
during the extraction process [24], [25].

1.3.3 SARS-CoV-2 Analysis

The discovery of fecal shedding of SARS-CoV-2 prompted worldwide experimentation
of quantifying SARS-CoV-2 through wastewater surveillance [26]. While there is currently no
single standard method for analyzing SARS-CoV-2 in wastewater, studies have been conducted
by multiple laboratories underneath the Water Research Foundation (WRF) and National
Wastewater Surveillance System (NWSS) to identify reliable, reproducible, and sensitive
methods [24][17]. This work has so far concluded that while various methods of RNA extraction
can be used, all laboratories will analyze the SARS-CoV-2 molecular signal via PCR using the
N1 and N2 gene target primer and probe sets designed by the CDC (Table 1)[24]. NWSS has
5

also concluded that the limit of detection for SARS-CoV-2 is yet to be properly established, and
therefore, wastewater surveillance cannot be used to determine if a community if free from
SARS-CoV-2 infection [17]. Wastewater surveillance is still considered a valuable resource, as
per capita incidence of COVID-19 can be estimated within a community through surveillance
data, daily wastewater flow rates, and population number [27].

Table 1. Primers and Probes used for RT-ddPCR reactions. *

Target
SARS-CoV-2
N1
SARS-CoV-2
N2

BCoV

BRSV

PMMoV

Primer/Probe Sequence (5'-3')
F: GACCCCAAAATCAGCGAAAT
R: TCTGGTTACTGCCAGTTGAATCTG
P: FAM/ACCCCGCAT/ZEN/TACGTTTGGTGGACC/lABkFQ
F: TTACAAACATTGGCCGCAAA
R: GCGCGACATTCCGAAGAA
P: HEX/ACAATTTGCCCCCAGCGCTTCAG/BHQI and
HEX/ACAATTTGC/ZEN/CCCCAGCGCTTCAG/lABkFQ
F: CTGGAAGTTGGTGGAGTT
R: ATTATCGGCCTAACATACATC
P: /FAM/CCTTCATAT/ZEN/CTATACACATCAAGTTGTT/IA BkFQ/
F: GCAATGCTGCAGGACTAGGTATAAT
R: ACACTGTAATTGATGACCCCATTCT

Supplier
Eurofins
Eurofins
IDT
Eurofins
Eurofins
IDT
IDT
IDT
IDT
IDT
IDT

P: /HEX/ACCAAGACT/ZEN/AGTATGATGCTGCCAAAGCA/I ABkFQ/

IDT

F: GAGTGGTTTGACCTTAACGTTGA
R: TTGTCGGTTGCAATGCAAGT

IDT
IDT
Applied
Biosystems

P: FAM/CCTACCGAAGCAAATG/MGBNFQ/

* Bovine Coronavirus indicated as BCoV, Bovine Coronavirus indicated as BRSV

1.4 Literature Gap and Research Contributions

In addition to wastewater variables, there are still uncertainties around SARS-CoV-2
RNA. The most pertinent uncertainties include: the rate and mass of virus RNA shedding in
feces during all phases of symptomatic and asymptomatic COVID-19 phases; the influence of
facility and sewershed-specific factors contributing to the wastewater matrix; and the virus
survival and persistence in the sewer and laboratory [32]. Fecal virus shedding has been the
6
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center of frequent debate since SARS-CoV-2 wastewater surveillance began. There are various
studies attempting to solve this question, however the most promising conclusion is that the
shedding of SARS-CoV-2 can vary greatly between positive COVID-19 patients. While one
study has proven 100% of COVID-19 positive patients shed fecal SARS-CoV-2 [33], the
average prevalence of COVID-19 positive patients that shed fecal SARS-CoV-2 RNA is closer
to 50% [34]. Of the patients that did shed SARS-CoV-2 in fecal matter, there was no significant
difference in shedding when comparing severity of the disease, or age of the patient [35].
However, patients with GI symptoms were almost twice as likely to exhibit fecal shedding than
patients who did not experience any GI related symptoms [36].

There is also uncertainty on how long of a period does SARS-CoV-2 RNA sheds. Many
studies have illustrated that SARS-CoV-2 RNA in feces can be detected for a longer duration
than respiratory and serum samples [26], [37]–[41] averaging around 22 days from the onset of
symptoms [34], [38]. This may result is a slight offset of the relationship of SARS-CoV-2
detected in wastewater, and clinical case rate. Assessments on SARS-CoV-2 fecal shedding are
oh high-priority, and are currently being performed by the clinical sector [42].

Other high-priority research opportunities declared by the WRF are effect of wastewater
pretreatment on genetic signal, and dilution or persistence of the genetic signal in the sewer
collection system [42]. Specific parameters in the sewer collection system that have a known
influence on viral RNA, and are assumed to have an impact on SARS-CoV-2 detection in
wastewater include pH, temperature, organic matter, solids content, residence time in the sewer,
sampling, and microbial antagonism [43]–[45].
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1.5 Goals and Objectives

This research seeks to provide information that can help fill gaps in current literature and
process’s encompassing wastewater surveillance of COVID-19. The main goal of this work is to
determine the impacts wastewater has on viral RNA to see how wastewater surveillance can be
more efficiently used for public health, and to confirm that it is a reliable metric. In doing this,
my research will cover three specific aims:

Specific aim 1: Analyze how wastewater data used for wastewater surveillance relate to
other public health metrics.
Specific aim 2: Explain the influence of wastewater conveyance systems on SARS-CoV2 virus survival and detectability by examining the relationships SARS-CoV-2 RNA
concentration has with wastewater parameters such as travel time, temperature, BOD,
TSS, and average daily flow rate.
Specific aim 3: Improve detection and quantification of SARS-CoV-2 for wastewater
surveillance using knowledge on the effects of parameters explored in previous chapters.

To answer these questions data analysis and experimentation will be performed in
addition to UW- Milwaukee’s weekly COVID-19 surveillance program that had been ongoing
since August 2020. Prior to any analysis performed for this thesis, we were already aware that
the COVID-19 trends detected from our wastewater surveillance data is significantly correlated
to the clinical COVID-19 case rate within that community [46] (Figure 2). The objective of
Chapter 3 is to assess how wastewater surveillance compares to other public health tools that are
being used for COVID-19. This was done by comparing data obtained from seven WWTP’s
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using reverse transcription droplet digital PCR (RT-ddPCR) on the Omicron variant to clinical
sequenced data. The objective of Chapter 4 is to determine if there is a measurable impact of
SARS-CoV-2 decay in wastewater throughout the residence time of an average sewer network.
To do this, SARS-CoV-2 loads from two interconnected sewer service areas with different travel
times were compared. Travel time was determined based off of metered velocity values, and
various parameters were analyzed for a correlation to SARS-CoV-2 load. The objective of
Chapter 5 is to determine possible improvements to COVID-19 wastewater surveillance based
off of results from SARS-CoV-2 persistence and decay analyses. To do this, SARS-CoV-2
concentrations from Jones Island Water Reclamation Facility (JI) sludge samples were directly
compared to wastewater influent from the same collection date to determine if signal of detection
could be increased or improved to better benefit public health.

Figure 2. Screenshot of the Wisconsin Department of Health Services (DHS) dashboard to illustrating
correlating data of COVID-19 infection trends in wastewater surveillance (top graph), and clinical case data
(bottom graph) in the SS WWTP service area.

9

Collectively, these results add knowledge and understanding to wastewater surveillance,
and can aid researchers when determining the best way to analyze and report data obtained from
wastewater surveillance programs. The overarching goal of this study is to reduce uncertainty
within this public health tool, and to contribute evidence that wastewater surveillance is an
effective method in tracking new and spreading diseases that can offer a wide spectrum of
applications for public health.
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Chapter 2: General Materials and Methodology

2.1 Collection of Influent Samples

Sewage influent samples were collected between August 30, 2020, and February 28,
2022, from nine wastewater treatment plants (WWTP) across Wisconsin, United States (Table
2). Flow-weighted 24-hour composite samples were collected twice per week, unless specified in
Table 2, by each WWTP according to the plant standard collection procedures and then
transferred to 500 mL bottles. Samples were stored at 4°C until shipped overnight on ice. Upon
arrival at the laboratory, samples were immediately stored at 4°C before processing within 24
hours. Influent chemical and physical measurements were provided by WWTP operators
employing their routine procedures for each sample.

Table 2. Operating Conditions of all WWTP's used throughout this paper.a

WWTP
Brookfield (BRK)
Cedarburg (CED)
Green Bay (PLT)
De Pere (DP)
Jones Island (JI)
South Shore (SS)
Oregon (ORE)
Racine (RAC)
Waukesha (WAU)

County
Waukesha
Ozaukee
Brown
Brown
Milwaukee
Milwaukee
Dane
Racine
Waukesha

Sample
Frequency*
2 x per week
1x per week
2 x per week
2 x per week
2 x per week
2 x per week
1x per week
2 x per week
2 x per week

Population
Served
51000
12000
189000
43000
470000
616000
10000
139000
73000

*CED and ORE only collected once per week
a
MGD is million gallons per day, MG is million gallons
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Capacity
(MGD)
13
3
49
14
330
300
2
36
39

Average
Flow (MGD)
8±1
2±0
24 ± 4
7±1
75 ± 23
74 ± 17
1±0
15 ± 4
7±1

Composite
Frequency (MG)
0.35
0.02
0.09
0.02
0.56 - 0.65
1.7
0.05
0.08
0.1

2.2 Processing Influent Samples
2.2.1 Pre-analytical processing
Wastewater samples were shaken vigorously until visually well-mixed, then 25 mL of
each sample were pipetted into 50 mL conical tubes containing 250 μL magnesium chloride
solution (MgCl2 ) to reach a final concentration of 25 mM. The presence of salts such as MgCl2
can enhance virus adsorption to cellulose ester membranes [47]. Approximately 100,000 copies
(5 μL) of BCoV were spiked into the solution to act as a recovery control, then the mixture is
poured into a magnetic filter funnel containing a 0.8 μm 47 mm diameter esters HA filter (MFMillipore, Carrigtwohill, Ireland). Samples were filtered at a low vacuum (~50 mmHg VAC)
until no pooled liquid is visible on the filter. Once the filtering was complete, the filter was
folded, and put into a 2 mL ZR BashingBead Lysis Tube (Zymo, Irvine, CA, USA) containing
buffer solution relevant to nucleic extraction protocol (Chapters 2.2.2-2.2.4).

2.2.2 Qiagen RNA Extraction Preparation
All samples prior to August 25, 2021, were extracted according to the RNeasy
PowerMicrobiome Kit (Qiagen, Hilden, Germany). The tube containing the filter and 650 µL of
PM1(PowerMicrobiome Kit by Qiagen) buffer solution are stored at -80°C for minimum of two
hours to improve RNA extraction yield. Once removed from the -80°C freezer, while still frozen,
the samples are spiked with 6.5 μL -mercaptoethanol and allowed to completely thaw before
bead-beating for 2.5 minutes, resting on ice for 5 minutes, then repeating to properly break-up
the filter. The samples are extracted following the RNeasy PowerMicrobiome Kit (Table 3)
Handbook with minor alternations, as explained in section 2.2.3.
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2.2.3 Qiagen RNA Extraction
All centrifugation for extraction is performed at room temperature at 150,000 revolutions
per minute (rpm) for one minute unless specified otherwise. After bead-beating, the samples
were centrifuged, and 450 µL of the supernatant was transferred to a Collection Tube.150 μL of
Solution IRS was spiked into the tube, vortexed briefly to mix, and incubated at 2–8°C for 5
minutes. After incubation, the samples were centrifuged, and avoiding the pellet, 650 μL of the
supernatant was transferred to a new Collection Tube. 650 μL of both Solution PM3 and
Solution PM4 were spiked and inverted until visually clear. 650 μL of the mixture was
transferred into an MB Spin Column and centrifuged, discarding flow-through and repeating
until all of the mixture passed through the MB Spin Column. 650 μL of Solution PM5 was
loaded into the MB Spin Column and centrifuged. The flow-through was discarded, and 600 μL
of Solution PM4 was transferred into the spin column. The samples were centrifuged, the flowthrough is discarded, then samples are centrifuged for an additional 2 minutes at room
temperature. The MB Spin Column was transferred to a clean 2 mL Collection Tube, and 60 μL
of warm RNase-Free Water was added to the center of the MB Spin Column membrane. The
samples were incubated at room temperature for 5 minutes and centrifuged. The 60mL flowthrough elution was transferred into a 0.5 mL Low Adhesion Surface Micrew Tube (Simport
Scientific, Bernard-Pilon Beloeil, QC Canada), and was frozen immediately at -80°C to preserve
RNA, until analyzed on RT-ddPCR.
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Table 3. components of RNeasy PowerMicrobiome Kit (Qiagen, Catalog number 26000-50)

Component
PowerBead Tube, Gloss O. 1 mm
Solution PM1
Solution IRS
Solution PM3
Solution PM4
Solution PM5
DNase Digestion Solution
Solution PM7
RNase-Free Water
DNase I (RNase-free)
MB RNA Spin Columns
Collection Tubes (2 ml)

Amount per Kit
50
55 mL
15 mL
36 mL
3 x 24 mL
3 x 30 mL
2 x 1.5 ml
23 ml
10 ml
1 vial (1500 units)
50
4 x 50

2.2.4 KingFisher RNA extraction
All samples after August 25, 2021, were extracted using a custom Maxwell® HT
Environmental TNA Kit (Promega, Madison, WI, USA) (Table 4) on an automated KingFisher
Flex instrument (ThermoFisher Scientific, Waltham, MA). Samples were thawed completely on
ice before bead bead-beating for 2.5 minutes, resting on ice for 5 minutes, then repeating to
properly break up the filter. Six purification plates were made prior to running the instrument:
two wash plates containing 100 μL of 50% ethanol and 900 μL of wash buffer (WBA) required
for purification, an Ethanol Wash plate with 450μl of 50% ethanol required for purification, an
elution plate with 100 μL of 25 mM Tris-HCl (pH 8.0), a plate containing KingFisher 96-tip
comb for reagent and sample transfer, and a Lysis and Bind plate containing 35 μL of Resin, 50
μL of Alkaline Protease solution (APA), 250 μL of cell lysis solution (CLD), 400 μL of
Isopropanol (100%) to each well required for purification. 250 μL of all sample supernatant
except SS (125 μL) was added to the lysis and bind plate. This instrument mixes the samples
while heating to complete lysis, then binds nucleic acid to the resin, washes the resin, dries the
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resin, and completes elution of the sample. The 100 μL elution was transferred into a 0.5 mL
Low Adhesion Surface Micrew Tube (Simport Scientific, Bernard-Pilon Beloeil, QC Canada),
and was frozen immediately at -80°C to preserve the RNA until analyzed on RT-ddPCR.
Table 4. Components of custom Maxwell® HT Environmental TNA Kit (Promega, Catalog number AX9190).

Component
MC1411
A176C
A2641
A175B
AX918A
A173C

Description
CTAB Buffer, 100 mL
Wash Buffer (WBA), 350 mL
25 mM Tris-HCl, pH 8.0, 60 mL
Resin, 5.5 mL
Alkaline Protease Solution, custom (APA), 60 mL
Cell Lysis Buffer (CLD), 160 mL

Amount per kit
1
3
2
4
1
1

2.3 Comparison of Extraction Methods
2.3.1. Introduction

Wastewater Surveillance of COVID-19 in our laboratory has been part of the NWSS
since August 2020 [48], but since then methods have evolved and improved to better detect and
monitor SARS-CoV-2 [25]. In 2020, our lab began performing RNA extraction using an oncolumn silica membrane commercial kit procedure (Chapter 2.2.2-2.2.3)[46], however, studies
have shown that magnetic bead approaches favor silica membrane approaches [49]. Methods
used for RNA extraction tend to be the most important variable in determining the positivity of a
sample for SARS-CoV-2, and even more so for laboratories lacking an automated nucleic acid
extraction system [50]. So, in August 2021, our lab began experimenting using an automated
magnetic-bead extraction procedure designed by the WI Department of Health Services (DHS).
The purpose of Chapter 2.3 was to prove that adapting our protocol improved the sensitivity of
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SARS-CoV-2 detection, especially in periods where there was a low prevalence of COVID-19
within the community.

2.3.2 Experimental Specific Methodology

To compare Qiagen and KingFisher extraction methods, 70 wastewater samples from
July 16, 2021, to August 19, 2021, were filtered in duplicate, so that each sample could be
extracted using both extraction methods. This analysis consisted of 152 total samples from 16
WWTPS in Wisconsin and North Carolina (Table 5). Samples were filtered, extracted, and
processed according to methodology in Chapter 2.

Table 5. Wastewater treatment plants included in the Qiagen versus KingFisher analysis and how many
samples from each WWTP was used in the analysis.

UWM WWTPs Samples DHS WWTPs³
Samples
BRK
7 Black River Falls
2
CED
6 Eau Claire
1
DP
7 Hayward
1
PLT
6 Madison-P18-NE
1
JI
7 Stevens Point
1
SS¹
7 Stevens Point
1
Sylva²,³
6 WI Rapids
1
RAC
7 Wolf
2
WAU
8
¹ Sample from August 18th was ran five times to ensure reproductivity of both methods
² North Carolina WWTP processed biweekly by UWM
³ Samples outside of biweekly UWM testing were not considered for full analysis

Sensitivity of each method was analyzed by comparing frequency of samples that were
detected below LOD, below LOQ, and above LOQ for both N1 and N2 targets, in addition to the
arithmetic average of N1N2 for all samples in Table 7. The N1N2 arithmetic average is what is
used for DHS and CDC reporting [51]. Box plots and corresponding statistics were computed,
and a Welch’s t-test was performed to determine if the extraction method significantly impacts
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SARS-CoV-2 concentration for only weekly-tested UWM samples indicated in Table 7.
Nonparametric Kendall’s tau was used to test if either extraction method had a better correlation
between the sewershed-specific case rate and SARS-CoV-2 concentration detected from the
wastewater sample for only weekly-tested UWM samples.

2.3.3 Results and Discussion

Extractions performed on the KingFisher detected significantly higher concentrations of
SARS-CoV-2 compared to Qiagen (Welch’s t-test, p < 0.005) in all WWTP’s except SS (Figure
3).

Figure 3. Box plot of the average N1N2 SARS-CoV-2 concentration in copies per liter for all samples above
LOD from eight WWTPs from both KF (pink), and Qiagen (blue) extractions. The lower and upper hinges
correspond to the 25th and 75th percentiles, the upper whisker extends from (1.5 * inter-quartile range (IQR)),
the lower whisker extends from (1.5 * IQR) of the hinge, plots beyond the whiskers represent outliers, and the
line in each box plot represents the median with a 95% confidence interval.
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We later determined that SS was producing lower signals due to inhibition, so we began
spiking half of the sample amount into the extraction (125 μL instead of 250 μL), and
compensated the volume removed with pure isopropanol as indicated in Chapter 2.5. The total
average concentration of all samples extracted via KingFisher increased concentration by 3-fold
when comparing those extracted using Qiagen (Figure 4).

Limits

Value

Target

Extraction

BLOD

10

N1

KF

BLOD

12

N2

KF

BLOD

10

AveN1N2

KF

BLOQ

12

N1

KF

BLOQ

9

N2

KF

BLOQ

9

AveN1N2

KF

quant

52

N1

KF

quant

53

N2

KF

quant

55

AveN1N2

KF

BLOD

12

N1

Qiagen

BLOD

21

N2

Qiagen

BLOD

10

AveN1N2

Qiagen

BLOQ

32

N1

Qiagen

BLOQ

34

N2

Qiagen

BLOQ

34

AveN1N2

Qiagen

quant

30

N1

Qiagen

quant

19

N2

Qiagen

quant

30

AveN1N2

Qiagen

Figure 4. Number of extracted samples that are below the limit of detected (BLOD), below the limit of
quantification (BLOQ), and above the limit of quantification (quant) from the Qiagen extraction (right
graph), and KingFisher (left graph) represented in a bar graph (left), and data table (right).

This increase in concentration caused KingFisher extractions to fall above the LOD
74.3% of the time, while Qiagen samples were only above the LOD 40.5% of the time (Figure
4). This method change ensured a higher probability of detection when COVID-19 cases are low
in the community. And, also improves the accuracy of quantification by increasing the number of
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samples over LOQ, which is defined as the lowest concentration at which the analyte can be
reliably detected [52].

Switching to the KingFisher did not significantly increase the correlation between the
case rate to detection in the sewershed (Kendall’s tau, p = 0.88), even with the removal of outlier
SS (Kendall’s tau, p = 0.31), within this dataset, but this could be for various reasons. These
include, but are not limited to the small sample size used in this analysis, the fact that cases were
relatively low during the period of this analysis, or that clinical testing data inaccurately reflected
true incidences, such as asymptomatic cases going without testing [53]. When comparing the
correlation of SARS-CoV-2 samples to clinical case rates in all KingFisher extracted samples
from January 1, 2021, to January 30, 2022, there is a significant correlation (Kendall’s tau, p <
0.005) (Figure 5).

Figure 5. Kendall’s empirical tau correlation on BRK, GB DP, GB PLT, JI, SS, RAC, and WAU on all
samples extracted via KingFisher that were reported to WI DHS until January 30, 2022 (n = 414).
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2.4 RT-ddPCR analysis
The SARS-CoV-2 reactions were set up following the One-Step RT-ddPCR Advanced
Kit for Probes by Bio-Rad (Table 5) using primer and probe sets designed by the CDC to target
the N1 and N2 regions of the SARS-CoV-2 N gene (Table 1). The primer’s final concentration
was approximately 900nM, and the probe’s final concentration was approximately 250nM. All
RT-ddPCR assays were performed in 22 μL reaction mixtures using the one-step RT-ddPCR
Advanced Kit for Probes (Bio-Rad, Hercules, CA) with volumes as indicated in Table 5.

Table 6. Assay used for SARS-CoV-2 detection in wastewater influent and sludge on RT-ddCPR.

Reagents
Supermix
RT
DTT (300 nM)
N1 Primers (18 uM each)
N1 Probe (5 uM)

Volume per well (μL)
5.5
2.2
1.1
1.1
1.1

Final concentration
1X
20 U/μL
15 mM
900 nM each
250 nM

N2 Primers (18 uM each)

1.1

900 nM each

N2 Probe (5 uM)
H2O
Sample
Total

1.1
3.3
5.5
22

250 nM
-

The RT-ddPCR assays were amplified using the Mastercycler pro (Eppendorf, Hamburg,
Germany) with settings as indicated in Table 6. Reactions were not kept at 4C for longer than 8
hours before being read using the Bio-Rad QX200 Droplet Digital System (BioRad, CA). Each
sample was run individually unless indication of the need for a rerun as described in Chapter
2.5.4. Raw droplet amplification data was extracted from the Bio-Rad QuantaSoft Analysis
software and processed using R package twoddpcr (version 1.11.0) in R-Studio (version
1.4.1103).
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Table 7. Mastercycler amplification settings.

Assay
N1
N2
BCoV
BRSV

PMMoV

Step
Reverse Transcription
Enzyme Activation
Denaturing
Annealing/Extension
Enzyme Deactivation

Cycle #
1
1
40
40
1

Temp C
50
95
94
55
98

Time (min)
60
10
0.5
1
10

Droplet Stabilization

1

4

30

Reverse Transcription
Enzyme Activation
Denaturing
Annealing/Extension
Enzyme Deactivation

1
1
40
40
1

50
95
94
60
98

60
10
0.5
1
10

Droplet Stabilization

1

4

30

2.5 Processing Controls
2.5.1 Recovery Controls
Bovine Coronavirus (BCoV) was spiked into each sample prior to filtration to act as a
recovery estimate for each filtration. The BCoV used was the Calf Guard cattle vaccine (Zoetis,
Parsippany, NJ) rehydrated with 3 mL of 1x TE buffer so that the final concentration per sample
is about 100,000 cp/μL for influent and for sludge samples. To define the concentration of the
hydrated BCoV stock solution, raw BCoV was extracted using the same protocol as the influent
or sludge then serially diluted 1:2 for four dilutions and run in duplicate using the BCoV assay
[1] according to the one-step RT-ddPCR. BCoV recovery (𝑅𝐵𝐶𝑜𝑉 ) was calculated as a ratio of
this value using the equations 1 and 2 in R-studio:

𝑅𝐵𝐶𝑜𝑉 =

𝐶𝑒𝑥𝑝 =

𝐶𝑜𝑏𝑠
× 100
𝐶𝑒𝑥𝑝

(1)

𝑉𝑅 ∗ 𝐶𝐵𝐶𝑜𝑉
× 1000
𝑉𝑆

(2)
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Where 𝐶𝑜𝑏𝑠 is the BCoV concentration in copies per liter of sewage detected in each
individual sample ran on ddPCR, and 𝐶𝑒𝑥𝑝 is the expected BCoV concentration in copies per liter
of sewage obtained as indicated in section 2.4.1. (𝑉𝑅 ) is the volume in uL of raw BCoV spiked
into solution, (𝐶𝐵𝐶𝑜𝑉 , ) is the concentration per uL of BCoV solution detected by the RT-ddPCR
reaction, and 𝑉𝑆 is the total sample volume in uL processed.
2.5.2 Fecal Strength Indicators

The fecal strength of untreated wastewater was determined by quantifying the human
marker, PMMoV, in each sample [31]. A 1:10 dilution of each sample was made if extracted
using the Qiagen Kit, a 1:40 dilution of each sample was made if extracted via KingFisher. An
assay was performed according to the one-step RT-ddPCR procedure as described in Chapter
2.4.

2.5.3 Inhibition Controls

The effects of untreated wastewater samples on RT-ddPCR amplifications of SARSCoV-2 were determined by comparing Bovine Respiratory Syncytial Virus (BRSV) prepared
from 25 doses of freeze-dried Inforce 3 Cattle Vaccine (Zoetis, Kalamazoo, MI, USA).
Inhibition was evaluated in each sample by spiking approximately 4000 copies of BRSV into
each RT-ddPCR reaction and comparing the concentration of each well to two reference wells
containing deionized water spiked with the same amount of BRSV made on the same plate. If the
ratio of any reaction to either of the reference wells was within 50%, it concluded that the
wastewater matrices had negligible inhibitory effects on the detection of SARS-CoV-2 RNA
[46], [54].
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2.5.4 Additional Quality Control

For all RT-ddPCR assays, two no-template controls (NTC) using nuclease-free water
were run to ensure no contamination occurred. Each run was analyzed only if both NTCs per
assay were below the limit of detection (LOD), which was assigned as 3 droplets (~0.2209
copies/uL). If either NTC was above the LOD, the entire assay was rerun. For the N1/N2 duplex
assay, duplicate 1:8 diluted Exact Diagnostics SARS- CoV-2 standard (Bio-Rad) wells were
used in each run as a standard control. Both standards were confirmed to be approximately 100
droplets prior to processing the plate. See Feng et. al. for further in-depth description of
processing controls and determination of LOD and limit of quantification (LOQ) [46].

2.6 Data analysis

All data compilation and statistical analysis were performed in R-Studio version 1.4.1103
[55]. All samples used for analysis are above the LOD, and none exhibited inhibition. Specific
statistical tests utilized for each experiment are explained within that chapter under
“Experimental Specific Methodology.”
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Chapter 3. Wastewater surveillance using RT-ddPCR accurately tracked Omicron
emergence due to altered N1 probe binding efficiency

3.1 Introduction

A portion of this chapter was previously published as a preprint by medRxiv [56] and is
currently undergoing peer review for publication in Environmental Science: Water Research &
Technology.

Mutations of the COVID-19 virus in the form of variants have also caused pressured
adaptations of laboratory methodology. The Omicron variant is unique in that it contains a high
number of mutations that appeared sporadically with the nearest ancestral strain last documented
in the community almost a year previously [57]. While most mutations accumulate in the spike
protein, Omicron also contains a mutation in the N gene that corresponds to the N1 probe
binding site of the CDC assay [58]. RT-ddPCR platforms provide data for individual molecules
and can reveal a decreased but positive fluorescence intensity in discrete reactions. One study
reported the Omicron mutation in the N1 probe of the CDC assay did not perturb N1 detection
but did note a slightly reduced cycle threshold (Ct) value for the N1 target [59]. The purpose of
Chapter 3 was to illustrate how RT-ddPCR may be a preferred platform for wastewater
surveillance since it was able to accurately track the Omicron variant emergence and fixation due
to the diminished fluorescence signal in the CDC N1 assay.

3.2 Experimental Specific Methodology

We quantified SARS-CoV-2 N-gene, Delta variant, and Omicron variant concentrations
in influent samples in five communities as part of our ongoing WI SARS-CoV-2 wastewater
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surveillance program [51]. SARS-CoV-2 concentration and variant analysis for this paper
includes a total of 165 samples that were collected between November 14, 2021, and January 31,
2022. Samples were collected from seven WWTPs: BRK, DP, PLT, JI, SS, ORE, and RAC.
Samples were collected and processed according to Chapter 2. In addition to the RT-ddPCR
assay primers probes indicated in Chapter 2, mutation assays for the Delta and Omicron variants
used in this experiment (Applied Biosystems, Waltham, Massachusetts, USA) are shown in
Table 8.

Table 8. TaqMan SARS-CoV-2 Mutation Assays used for RT-ddPCR variant analysis. *

Target

Primer/Probe Sequence (5'-3')ª
Supplier
Ref
Reporter 1 dye: VIC, Reporter 1 Quencher: NFQ,
Delta
Applied
Reporter 2 dye: FAM, Reporter 2 quencher: NFQ
[60]
(P681R)
Biosystems
CTCAGACTAATTCTC[C/A]TCGGCGGGCACGTAG
Reporter 1 dye: VIC, Reporter 1 Quencher: NFQ,
Omicron
Applied
Reporter 2 dye: FAM, Reporter 2 quencher: NFQ,
[60]
(P681H)
Biosystems
CTCAGACTAATTCTC[C/G]TCGGCGGGCACGTAG
*RT-ddPCR primers and probes at a final concentration of 900 nM and 250 nM, respectively.
ªReporter 2 dye targets Mutant of TaqMan SARS-CoV-2 Mutation Panels.

Detection of the Omicron variant was derived from RT-ddPCR droplet data, which was
processed using the QuantaSoft Software, version 1.7, for the Bio-Rad QX200 Droplet Digital
System (Bio-Rad, Hercules, CA). Raw droplet amplification of the Omicron variant in each
sample was assigned using the lasso threshold adjustment tool to reclassify the cluster
delineation in the 2D amplitude scatterplots. To ensure the correct amplitude was being
associated with each respective variant, we included an Omicron and Delta residual clinical
sample diluted 1:100 in addition to two 1:8 diluted Exact Diagnostics SARS- CoV-2 standards
(Bio-Rad). Raw droplet amplification data for each variant and total N1 and N2 gene
concentration were extracted from the Bio-Rad QuantaSoft software and processed using R
package twoddPCR according to Chapter 2.
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To validate the observed diminished fluorescence corresponding to a mismatch at the
5’end of the N1 probe, we mimicked the same type of substitution in an artificial N2 template.
We synthesized a 300-basepair template that contained an A:C change in the third nucleotide
position of the N2 probe binding site (Twist Bioscience, South San Francisco, California, USA).
We tested this template in RT-ddPCR using increasing ratios of the SARS-CoV-2 standard and
of Omicron and Delta residual clinical samples and analyzed droplets as described above.

3.3 Results and Discussion

Throughout late November through December 2021, we found that SARS-CoV-2 levels
steadily increased and the N1 signal in RT-ddPCR could be separated into two distinct clusters,
one with lower fluorescence than expected based on the N1 standard (Figure 6). The Omicron
variant has a C to U mutation at position 28,311 in the SARS-CoV-2 genome, which corresponds
to the nucleotide position on the 5' end of the probe for the CDC N1 PCR assay [28]. The loss of
fluorescent signal is likely due to inefficient exonuclease activity of the Taq polymerase on the 5'
end of the probe which releases the fluorophore from the quencher.
Dec 01 to Dec 08

Dec 09 to Dec 15

Dec 16 to Dec 22

Channel 1 Amplitude

Dec 23 to Dec 29
5.2%

68%

55%

82%

Channel 2 Amplitude
Sequenced clinical samples
11/190 (5.7%) Omicron

Sequenced clinical samples
58/129 (45%) Omicron

Sequenced clinical samples
85/115 (74%) Omicron

Sequenced clinical samples
49/54 (90%) Omicron

Figure 6. Wastewater N1N2 multiplex RT-ddPCR results in JI throughout December 2021 during the Omicron
variant surge. A reduced fluorescence in the N1 signal in Channel 1 (green droplets) resulted in two clouds and
was indicative of Omicron. N2 signal is in Channel 2 (pink droplets). Channel 1 and 2 fluorescence in the same
droplet indicate both N1 and N2 target are present (yellow droplets) Negative droplets are blue. Clinical patient
samples sequenced from Milwaukee County each week are indicated below graph (data from GISAID).
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We verified the loss of fluorescence due to the C to U mutation by synthesizing a DNA
template containing a similar nucleotide change in 5' end of the N2 probe binding region. The
third position of the N2 probe was substituted (A:C). We found fluorescence diminished similar
to what was observed in the Omicron variant (Figure 7). The effects of probe mismatches on
fluorescent signal have been previously reported [61]. The probe is impacted more by mutations
nearer the 5' end, in contrast to primers, where mismatches in the 3' end are more likely to affect
the extension activity of the polymerase [62]. Overall, mutations in the probe rather than the
primers are more likely to result in reduced quantification [63].

Channel 1 Amplitude

Standard N2

N2 Template

50/50 Mixture

Channel 2 Amplitude
Figure 7. N2 multiplex ddPCR results of 1:8 diluted Exact Diagnostics SARS- CoV-2 standards (Bio-Rad) (top
image), 1:100000 diluted (1 ng/uL) 300bp linear synthesized DNA N2 sequence with A:C mutation on the third
base pair (Twist Bioscience) (middle image), and a 50/50 mixture of both samples (bottom image). Channel 1
amplitude above baseline (i.e., N1 signal, not shown).
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We validated the accuracy of quantifying the Omicron variant using the N1 cloud splits
with the TaqMan SARS-CoV-2 Mutation Panels S.P681R.CCT.CGT (Delta) and
S.P681H.CCT.CAT (Omicron) (ThermoFisher Scientific, Waltham, MA) in two WWTPs. A
significant positive correlation was observed between the specific mutation assay and N1 cloud
split quantification for Omicron (Spearman’s rank correlation, rho = 0.845, p < 0.005) and Delta
variants (Spearman’s rank correlation, rho = 0.785, p < 0.005). The trends in the variant
concentrations mirrored each other (Figure 8), but overall, the N1 assay was more efficient (i.e.
higher number of droplets) than the specific mutation assays.

Figure 8. Comparison of the quantification of Omicron and Delta mutant droplets using the TaqMan SARS-CoV-2
Mutation panels and N1 probe cloud split methods.

We also compared the proportion of Omicron and Delta in wastewater with sequencing
results from clinical samples available in GISAID [64] for the communities serviced by seven
WWTPs (Figure 9). We assumed that county-level data would be a proxy for different cities
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within the county. There was good agreement between WWTPs within the same city or county,
and in all cases, the WWTP serving the larger population detected omicron earlier.

Figure 9. Heat map of percentage of Omicron in (a) WWTP samples determined by RT-ddPCR and (b) clinical
samples determined by sequencing as reported in GISAID. In general, the WWTP samples showed a more
gradual progression. Gray bars indicate no clinical samples were sequenced in the counties in which those
cities are located.

In all WWTPs, Omicron was detected greater than the LOD prior to the first clinically
confirmed case of Omicron (Table 9). Our first sample indicating a second N1 cluster above the
LOD was a sample from November 21, 2021, one day prior to the first diagnosed clinical
Omicron sample in the US. This date is identical to east and west coast wastewater detection
[65], but is noteworthy as variants of concern are not usually first observed in Midwest states.
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Table 9. Dates of first detection of Omicron by whole genome sequencing of clinical samples and routine
analysis of RT-ddPCR of wastewater samples.
Days from first
First
First >LOD
WWTP
County
>LOD to 75%
clinical
wastewater
Population
Omicron
Racine
Racine
5-Jan-22
5-Dec-21
28
139000
Oregon
Dane
12-Dec-21
8-Dec-21
29
10000

Milwaukee SS

Milwaukee

1-Dec-21

21-Nov-21

35

615934

Milwaukee JI
Green Bay PLT

Milwaukee
Brown

1-Dec-21
30-Dec-21

5-Dec-21*
28-Nov-21

21
39

470007
189000

Green Bay DP

Brown

30-Dec-21

6-Dec-21

27

43000

Brookfield

Waukesha

7-Dec-21

28-Nov-21

30

51000

*Milwaukee JI 17-Nov-21 sample was run in two RT-ddPCR wells to increase sensitivity and found to be >LOD.

When comparing our wastewater data to sequenced clinical samples, we saw a later onset
of Omicron in clinical samples, with a more rapid spike in percentage. In addition, there were
various instances where no clinical samples were sequenced for that county. The low number of
clinical samples sequenced for less populated parts of the state might not accurately portray
proportions. For example, 21 clinical samples were sequenced in Racine County and 23 in
Brown County for the entire month of December. Because clinical sequencing may not be
equally resourced across a state, the results of wastewater testing are expected to be more
consistent. Further, sequencing of clinical samples might be biased toward testing for variants in
samples from vaccinated individuals or in samples with S gene target failure, which can be an
indicator of specific variants [66].

We further examined wastewater dynamics through the pandemic and found the
emergence and shift to dominance of the Alpha, Delta, and Omicron variants was characterized
by increasing percentages in wastewater over increasingly shorter time frames (12 weeks, 7
weeks, and 2-4 weeks, respectively) (Figure 10). For each variant shift, the total abundance of

30

viral signal in wastewater reached higher levels than previous surges. Clinical testing has
changed dramatically over the pandemic, however, we found wastewater pattern mirrors the
dynamics captured with traditional clinical testing and sequencing [67].

Figure 10. SARS-CoV-2 levels determined by averaged N1 and N2 levels in wastewater during four
surge periods and the level of each variant. Alpha variant became dominant (>50%) in 12 weeks, Delta
in 7 weeks, and Omicron became dominant in 10 days, with the highest N1N2 levels ever seen in
wastewater. The increase in the variants preceded the increase in overall N1N2 concentrations.
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Chapter 4. Effect of Wastewater Matrix on SARS-CoV-2 in Municipal Wastewater
Conveyance Systems

4.1 Introduction

A section of this chapter has been published by Water [68]. The goals of this chapter
were to obtain an accurate residence time of two sewer networks to examine travel time effects
on decay and to determine how wastewater parameters may affect SARS-CoV-2 RNA
concentrations entering wastewater treatment plants (WWTPs). Because SARS-CoV-2 is an
enveloped positive-sense single-stranded RNA virus [69] its outer lipid layer may render it more
sensitive than other viruses to temperature, organic solvents, and other constituents encountered
in the wastewater conveyance system [70]. While various studies have performed analysis on the
decay of coronaviruses, and specifically SARS-CoV-2 RNA in wastewater influent in a
laboratory setting, they are often done with surrogate SARS-CoV-2 RNA spikes [43], [71]–[74]
which have been shown to behave differently than authentic in-situ SARS-CoV-2 found within
the wastewater matrix [75], [76]. A major barrier to performing in-situ studies and comparing
across real wastewater systems is that the true input of SARS-CoV-2 virus from the population is
unknown and likely different for individuals depending on the severity of disease, stage of
infection, and other factors [34].

This study utilized two wastewater service areas, with one surrounded by a second large
one, that service a single large metropolitan area. The similar case rates and close geographic
proximity allowed us to analyze how various parameters can affect SARS-CoV-2 concentration
during the residence time within each sewer network. In this study, the approximate travel time
at different flow rates (average, maximum, and minimum) for two service areas were
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determined. The two conveyance systems have different travel times, which we used to assess
the loss of SARS-CoV-2 signal during longer travel times. We also examined the effect of flow
rate, temperature, BOD, and TSS on SARS-CoV-2 (N1 and N2 targets) in both WWTPs.
Additionally, to gain insight into dilution effects, we analyzed the flow rate, and human fecal
(PMMoV) concentration. It was determined that within typical residence times (up to 100 hours)
of SARS-CoV-2 within the wastewater matrix, temperature was the only parameter that had a
significant influence on SARS-CoV-2 concentrations.

4.2 Experimental Specific Methodology

4.2.1 Study Area and Engineered Parameters
The Milwaukee Metropolitan Sewage District (MMSD) is comprised of two separate
WWTPs; JI which serves a population of 470,007 residents, and SS which serves a population of
615,934 residents in Milwaukee County, Wisconsin, USA (Figure 11). A portion of JI (37%)
services a combined sewer system, meaning that industrial, urban, residential, and environmental
run-off all contribute unique factors to the wastewater matrix. SS serves a much larger area, and
its sewer network is better equipped for larger flows (average pipe diameter SS = 43.6 inches,
average divertible pipe diameter from JI = 32.8 inches). Under high flow conditions, 47% of JI
sewers can be diverted to SS (Figure 11) to avoid sewer back-ups. This diversion only increases
the SS sewer network by 11%. Overall, the SS conveyance system is comprised of a larger surface
area and has longer travel times.
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JI Legs SS Legs
A1
A3
B1
B2
C
D2
SB
D3
ST
E
T
F1
U1
F2
V
G
W
H
XB
I
XT
J1
A2*
J2
B3*
K1
D1*
K2
OP*
L1
U2*
L2
M
N
Q
R1
R2
R3
R4

Figure 11. MMSD sewer tributary areas consisting of 162,373 acres of land divided between JI and SS sewer systems.
Collectively 131,756 acres goes to SS WWTP (blue), and 30,617 acres goes to JI WWTP (green). 14,334 acres of JI service
area can be diverted to SS under high flow conditions (dark red). Divertible maintenance pipes are indicated by light red. The
legend indicates which legs (labeled on map) flow to which WWTP. Legs with an * indicate legs that are diverted to SS under
high flow conditions, this area makes up 11% of the SS service area. Map provided by MMSD.
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4.2.2. Sampling

Our analysis included a total of 186 samples that were collected biweekly between August
26, 2020, to August 22, 2021, from JI and SS WWTPs that were collected and processed as
indicated in Chapter 2. The average parameter values confirmed that both conveyance systems
had similar conditions except for biological oxygen demand (BOD) (Table 10).

Table 10. Comparison of JI and SS parameters across all samples (n=186), and in warmest (n=70) versus
coldest (n=38) months. Samples are collected from an automated samplers at MMSD reclamation facility,
aliquots are removed by WWTP operators.

Parameterª
Warmest temperatures (°C)
Coldest temperatures (°C)
Annual temperature (°C)
Warmest Daily Average Flow Rate (MGD)
Coldest Daily Average Flow Rate (MGD)
Annual daily average flow rate (MGD)
Warmest TSS (mg/L)
Coldest TSS (mg/L)
Annual TSS (mg/L)
Warmest BOD (mg/L)
Coldest BOD (mg/L)
Annual BOD (mg/L)
ªTotal suspended solids indicated as TSS
*Significantly different values

SS Average
17.86
10.97
14.9
82.29
92.58
79.00
267.71
253.16
273.00
331.43*
314.74
343.00*

JI Average
18.54
10.35
15.30
89.69
86.32
83.30
247.69
233.16
245.00
271.40
248.95
273.00

4.2.3. Travel Time Calculation
The MMSD sewer system is a complex network containing 39 separate legs of large pipes
comprising a municipal interceptor system that eventually flow to either JI or SS WWTP. Each
leg was assigned a different letter or letter combination (Figure 11). The approximate minimum,
maximum, and average travel times were calculated for both JI and SS using equation 3.
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𝑇ℎ =

𝐿
(𝐵 )

(3)

𝑉

Where the travel time in hours in hours (𝑇ℎ ) is equal to the total leg length in meters (L),
divided by the number of branches within a leg that lead to the same outfall (B), divided by the
metered velocity in meters per second (V), which was measured hourly. A total of 56.5% of the
velocity values fell below the average and 43.5% above the average.
MMSD provided hourly velocity data captured from individual meters throughout 33 of
the 39 legs, excluding B1, R4, ST, U1, XB, and XT, for the entire timeline of our sample collection.
Additional information used to complete the calculation included the location of each meter within
the treatment system, the length, diameter, and slope of each pipe, the inlet and outlet pipes of each
leg, and the direction of flow. Velocity from four representative subsewersheds in SS and three
representative subsewersheds in JI are displayed in Figure 12.

Figure 12. All positive hourly metered velocity readings from four representative subsewersheds in SS WWTP
(within legs Q, R2, SB, T), and three representative subsewersheds in JI WWTP (within legs C, F1, I) over the
course of this study.
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Various instances of negative velocity values were collected at each meter, which indicates
the sensor was not measuring accurately at that time. This could have resulted from a variety of
issues including fouling, debris, equipment failure, poor flow conditions, or levels below necessary
minimums. For this analysis, all negative values were removed from the dataset. Using only the
positive values from the 13,128 hourly readings for each meter between January 1, 2020, to July
1, 2021, the minimum, maximum, and average velocities were calculated in R-Studio for each
metered section. For the six legs mentioned above that were not metered, approximate velocity
values were estimated using an average of the most similar pipes according to slope, length,
diameter, and location (Table 11).

Table 11. Estimated travel times using approximation of most similar legs. All legs used for this analysis were
in urban areas. The average slope and average diameter are both listen in inches.

Leg
B1
ST
U1
XB
XT
R4

Slope
0.004
0.007
0.001
0.014
0.005
0.006

Diameter (in.)
41
50
36
27
61
48

Matched to
R2
D3
U1
SB
Q
R2

Slope
0.004
0.006
0.001
0.019
0.004
0.004

Diameter (in.)
43
44
34
33
46
43

To avoid unattainably high or low travel times the absolute minimum and maximum
velocities of each leg were not used. Rather, to simulate high-flow travel times metered
measurements from the highest summed velocity readings from each leg was used. The time for
this collection window was May 17, 2020, at 16:00. To simulate low-flow travel times, the date of
the lowest sum of total velocity measurements was applied to each leg of the conveyance system.
November 23, 2020, at 4:00 provided the lowest hourly velocity readings. Leg G had no measured
metered velocity on May 17th, so the absolute maximum velocity of that leg (0.637 m/s) was used.
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The absolute minimum velocity of each leg was used where negative velocity readings were
collected due to levels being too low for accurate meter readings. Out of the entire data set,
minimum values were supplemented for leg D2 (0.365 m/s), leg E (0.015 m/s/), leg M (0.021 m/s),
leg N (0.015 m/s), and leg V (0.055 m/s). For the average travel time estimate, the arithmetic
average velocity for each meter was used. While the sewer system is designed to divert an
additional 10% of acreage to SS under severe high-flow conditions, diversions were not considered
because they are rare events. Further, flows to each respective WWTP during diversions only
minimally affects travel times (Supplemental Table 12).

4.2.4. Temperature Analysis

The temperature analysis was done using hourly metered temperature data from four
representative subsewersheds in SS and three representative subsewersheds in JI provided by
MMSD (Figure 13). Daily temperature was calculated for each sample collection date summing
the arithmetic average temperature for each meter respective to SS and JI sewersheds. Over the
course of the year, the lowest recoded temperature was 6.05C and the warmest was 21.73C. To
compare how much of an effect temperature had on SARS-CoV-2 case adjusted concentration, we
compared data from the warmest (August, September, October), and coldest (February, March,
April) months.
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Figure 13. Hourly metered temperature readings from four representative subsewersheds in SS WWTP
(within legs Q, R2, SB, T), and three representative subsewersheds in JI WWTP (within legs C, F1, I)
over the course of this study.

4.2.5. Time and Temperature Analysis
After determining JI has a shorter travel time than SS, we hypothesized that SARS-CoV-2
copies per diagnosed case should be equal for the two service areas if travel time did not affect
measured concentrations. We assumed that the amount of case under-reporting would be similar
for the two populations. We confirmed that the case rate was equal in both sewersheds (Paired ttest, p = 0.81), supporting our assumption. The difference in copies per case would reflect the
influences of the conveyance system environment such as effects of temperature, or decay during
longer travel time.
To normalize between JI and SS service areas, quantified RT-ddPCR SARS-CoV-2 RNA
concentrations were expressed as copies per case per day (𝐶𝑝 ) using the equation 4.
𝐶𝑝 =

(𝐶 × 𝑄)
𝑅

(4)
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Where C is SARS-CoV-2 RNA copies (in millions) per liter of wastewater, Q is the flow
of the sewershed (in million liters per day), and R is the number of reported clinical cases (day of
collection) on the day of wastewater sampling. All clinical data was obtained from Office of Health
Informatics and the Bureau of In-formation Technology Services at the Wisconsin DHS and is
reported as date of sample collection. Date of clinical sample result from each WWTP service area
can be downloaded from https://www.dhs.wisconsin.gov/covid-19/wastewater.htm#wastewater.
When determining how flow diluted the signal, flow was removed from this equation, resulting in
SARS-CoV-2 concentration (𝐶𝑓 ) being calculated using equation 5.
𝐶𝑓 =

𝐶
𝑅

(5)

4.2.6. Statistical Analysis
Nonparametric Kendall’s tau was used to test hypotheses’ regarding correlations between
variables and SARS-CoV-2 copies per case, and t-tests were used to test hypotheses regarding
relationships and trends with the data. Comparing two interrelated WWTPs; one with a long
travel time (up to 109 hours), and one with a short travel time (as low as 4 hours), we used a
paired t-test to determine if time impacts SARS-CoV-2 copies per case within the wastewater
conyence system.
Welch’s t-test was used to analyze how each parameter (temperature, flow, BOD, TSS)
impacts SARS-CoV-2 copies per case. We further examined the temperature data for significant
outliers using a one-way analysis of variance (ANOVA), and posthoc Tukey Honestly Significant
Difference (HSD) analysis in R-Studio to compare each month within the warm (August,
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September, October) versus cold months (February, March, April) data sets. We further analyzed
how much flow can dilute the fecal matter in the wastewater using Kendall’s rank coefficient to
compare human fecal marker PMMoV, and average daily flow rate.

4.3 Results

4.3.1. Travel time determinations and influences on SARS-CoV-2 decay
The average travel time for SS was approximately 3 times longer than JI (Table 12), and
the ratio scaled similarly when comparing high and low flow conditions. Using velocity
measurements from May 17, 2020, to simulate high flow conditions, SS transit was
approximately 2.75 times longer than JI. And when using the minimum velocity to simulate lowflow conditions, the difference in travel time rose to almost 6 times longer. The simulated lowflow travel times (using the minimum velocity) within a WWTP lengthen the average residence
time in the sewer network up to 5 times longer than high-flow conditions simulated with
maximum velocity.

Table 12. Average, and simulated low-flow (maximum), and high-flow (minimum) travel times in hours in JI
and SS WWTPs. The data was compiled using the length of each pipe, and the average velocity from 33
metered sites across 39 legs in the MMSD sewer network.

WWTP
JI
SS

Minimum Travel Time* (h)
4.68
12.88

Average Travel Time (h)
7.45
22.16

Maximum Travel Time (h)
11.36
63.45

*Minimum travel time with diversions is estimated to be 5.25 hours for JI and 13.17 hours for SS as indicated in
Supplemental Figure 2.
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In general, travel time had little effect on SARS-CoV-2 concentrations entering the
WWTP. An increase from approximately 7.5 to 22 hours only resulted in a 10% decrease in
average copies per case when comparing JI and SS travel times. Further, estimated decay rates
are negligible (Appendix 2). While there was not a significant difference in the SARS-CoV-2
copies per case detected from the WWTPs, there was a trend shifting towards significance
(paired t-test, t=1.741, p = 0.08) indicating that while there is minimal difference in decay within
the first ~24 hours of travel time, significance may increase if the travel time increases. We
further examined the difference in the SARS-CoV-2 copies per case (i.e., case-adjusted loads)
under high-flow and low-flow conditions by using the maxmium and minimum third of daily
average flow rates (Figure 14). We expected under high flow conditions, there would be no
difference in copies per case between the WWTPs since travel time differs by only ~8 hours,
which was confirmed by our analysis (Figure 14). When simulating low-flow conditions by
considering minimum flow in all legs, there is up to an ~80-hour difference in travel time;
however, we also did not observe a difference in JI vs. SS case-adjusted loads between,
suggesting that the SARS-CoV-2 signal is not affected by travel time.
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Figure 14. Case-adjusted loads (daily) among the highest and lowest third of
average daily flow rates from 62 pairs of samples from JI and SS WWTPs.

4.3.2. Influence of flow
We investigated how flow might affect concentrations beyond the effect of the shorter
travel times. Therefore, we examined if higher flows had a proportional reduction (i.e., dilution)
on case-adjusted concentrations and of PMMoV. PMMoV is a human fecal marker that is widely
present in the human population, that acts as a measure of fecal contribution. SARS-CoV-2 caseadjusted concentrations were on average 50% higher in high flows compared to low flows in JI
(Welch’s t-test, p = 0.01). This might be suggestive of the addition of SARS-CoV-2 due to scouring
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with high velocities, as opposed to a dilution effect. SS case-adjusted concentrations were slightly
higher with high flows, but this was not significant (Welch’s t-test, p = 0.14) (Figure 15).

SARS-CoV-2 Copies per Case

PMMoV Concentration per Liter Wastewater

8 × 108
6 × 108
4 × 108
2 × 108
0

3 × 108
2 × 108
1 × 108
0

Figure 15. Kendall's rank correlation of case-adjusted concentration (copies/L/case) (left) and PMMoV
concentration (right) to daily average flow rate (MGD) in JI (top) and SS (bottom). Outliers in PMMoV analysis
were removed for the visual data. P-values including total dataset are included in the text.

The percentage of human fecal contribution had a low, but significant, correlation to flow
in both WWTPs (Figure 15) (Kendall’s tau, p < 0.05), that was stronger in SS (Kendall’s tau, p =
0.008) than JI (Kendall’s tau, p = 0.035). Unlike SARS-CoV-2, PMMoV decreased slightly with
increasing flows, but not to the extent expected if dilution was occurring.

4.3.3. Influence of BOD and TSS
Overall, there was either no or very low correlation between BOD or TSS and case-adjusted
loads. The low negative correlation in JI of BOD to case-adjusted loads was deemed significant
(Figure 16), but considering JI had overall higher case-adjusted loads and lower BOD than SS
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WWTP (Table 10), we can infer that BOD does not have a substantial effect on SARS-CoV-2
concentration entering the plant.

2.0 × 105
1.5 × 105

SARS-CoV-2 Copies per Case

1.0 × 105
5.0 × 104

2.0 × 105
1.5 × 105
1.0 × 105
5.0 × 104

0

Figure 16. Kendall's rank correlation of BOD (mg/L), and TSS (mg/L) to SARS-CoV-2
copies per case in JI (top) and SS (bottom) WWTPs.

4.3.4 Influences of Temperature
SARS-CoV-2 case-adjusted loads were on average 40-55% higher in colder months
compared to warmer months in both SS (Welch’s t-test, p = 0.04) and JI (Welch’s t-test, p = 0.02)
suggesting there is less decay in JI and SS conveyance systems in cooler temperatures (Figure 17).
These temperature effects occurred, despite the short travel time in the JI service area that would
subject SARS-CoV-2 to temperature effects. We further examined that temperature was
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significantly negatively correlated to SARS-CoV-2 copies per case in both plants (Kendall’s tau,
p < 0.05). August was the only significant outlier in any grouping for both WWTPs (ANOVA, p
< 0.05), August also had the highest flow of all warm months (Supplemental Figure 1). For a better
sense of the influence of temperature has on concentration, best-fit equations are included in

SARS-CoV-2 Copies per Case

Appendix 3.

Figure 17. SARS-CoV-2 copies per case during warmest (17.41 – 19.75ºC) and coldest
months (8.60 - 12.27ºC) in SS and JI WWTPs.

4.4. Discussion
Wastewater surveillance is increasingly being used by public health officials to monitor
COVID-19 prevalence and respond accordingly to help contain and mitigate outbreaks in
specific communities [48]. Researchers across the country are implementing this tool, despite
critical gaps in the knowledge on how SARS-CoV-2 recovery is affected within untreated
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wastewater entering WWTPs [16], [43], [77], [78]. While laboratory-based studies have been
performed to determine viral decay under certain temperatures over time [43], [71], our study has
the benefit of access to a wastewater system that is highly instrumented for flow and
temperature. Both JI and SS fall under the supervision of MMSD which allows the comparison
of two treatment plants with different travel times with nearly identical data collection,
maintenance, treatment, and supervisory standards. This enabled us to evaluate the impact of
various parameters on SARS-CoV-2 concentration within the residence time of a sewer
conveyance system. The paired design of the study allowed us to control for common parameters
such as temperature or rainfall (increasing flow) when comparing travel times since both systems
were subjected to similar environmental conditions.
We hypothesized that under high-flow conditions when travel times are shortest, there
would be no difference in copies per case between the two plants. Under low-flow conditions,
when travel times are the longest and there is the greatest difference between JI and SS, we
would expect to observe difference in SARS-CoV-2 case-adjusted loads. Overall, we found that
there was minimal SARS-CoV-2 decay with travel time, suggesting this is not an important
parameter to consider in comparisons of different sewer systems.
Wastewater surveillance programs generally use measured concentrations multiplied
times flow to calculate the load. Since approximately the same number of people in the service
area contribute biological material to the sewer system in high- or low-flow conditions, we
expect that SARS-CoV-2 or fecal markers such as PMMoV would be proportionally diluted with
the flow. However, we found no effect, where SARS-CoV-2 case-adjusted concentrations were
not proportionally reduced. The same analysis with PMMoV also showed no proportional
dilution, however, there were slight decreases in PMMoV concentrations in high flow
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conditions. Higher flows can result in shorter travel times and less decay which could account for
this pattern, but our time travel analysis suggests differences in decay over typical residence
times are minimal.
Previous work found calculating loads using flow did not increase the correlation
between cases and SARS-CoV-2 concentrations compared with simply using concentrations
[46]. High flows result in scouring, which could inject residual SARS-CoV-2 into the waste
stream, however, this explanation was also not supported as we did not observe an increased TSS
with increased flow. Additional studies are needed to examine how reservoirs might accumulate
and be mobilized in conveyance systems, which can span thousands of miles of pipes in urban
areas. While most reporting is normalized to flow [54], the practice to include flow in assessing
SARS-CoV-2 trends needs further consideration.
We determined that TSS had a negligible effect on SARS-CoV-2 case-adjusted copies
detected in wastewater, which is comparable to other literature [79]. And, while BOD was
significantly higher in SS than in JI, we can conclude that there was no direct impact of SARSCoV-2 from BOD because the copies per case were not significantly higher in either plant
despite significantly different BOD levels. Further negating significance, JI illustrated a low but
significant negative correlation with BOD but had overall lower BOD levels and higher SARSCoV-2 case-adjusted copies. In addition, BOD is known to be tightly correlated to temperature
[80], so this low correlation may be a direct result of temperature.
Temperature had the strongest effect on SARS-CoV-2 viral concentration (Kendall’s tau,
p < 0.05), significantly reducing observed concentration exposed to warmer conditions in JI
(paired t-test, p = 0.02), and SS (paired t-test, p = 0.046). Temperature posing a significant effect
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on SARS-CoV-2 decay is consistent with other studies that indicate coronaviruses, and
specifically SARS-CoV-2, are sensitive to warmer temperatures [32], [43], [81]–[83] where
decay rates for similar temperature windows ranged between 0.021-2.16 k/day [32], [43], [72],
[73]. Because increasing temperatures reduce RNA stability, and make it more difficult for any
virus to survive [84], the significant results derived from this study’s small temperature range is
not abnormal. Previous studies have shown that increasing the temperature from just 4°C to 10°C
can more than double the decay rate of SARS-CoV-2 RNA, measured through detection of the
N1 and N2 gene [83].
In all, temperature is the only parameter crucial to consider when interpreting empirical
values for SARS-CoV-2 concentrations in wastewater, especially when combined with longer
residence times due to low-flow conditions and extensive sewer networks. The residence time of
a sewer conveyance system can change vastly on any given day due to weather conditions, or
industrial drainage; it is important to take this into account when determining or applying the
decay rate within a sewer network.
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Chapter 5. Increasing Sensitivity of SARS-CoV-2 Detection with Primary Settled Solids

5.1 Introduction
The goals of this chapter are to explore how wastewater parameters can be considered to
further improve SARS-CoV-2 detection for wastewater surveillance in our laboratory. While
Chapter 4 illustrated that influent TSS did not have a significant impact on SARS-CoV-2
detection in wastewater, influent usually only contains around 1 percent total solids.
Additionally, studies have shown solids can conglomerate and protect enveloped viruses, such as
SARS-CoV-2 [85][86] because the lipid membrane favors binding to solids over liquids [87]. In
the wastewater treatment process, raw wastewater enters the primary clarifiers where solids are
settled out of the liquid fraction of wastewater (Figure 18) forming a semi-solid slurry referred to
as “sludge” that is approximately 3-5 percent solids [88]. Various laboratories use primary
settled solids, or sludge, instead of influent for their wastewater surveillance, and have achieved
similar detection sensitivity with less sample volume [85]. To further examine if solid content
effects SARS-CoV-2 detection levels by protecting RNA, the SARS-CoV-2 concentration
extracted from both JI wastewater influent and sludge was compared.

Figure 18. The wastewater treatment process performed at MMSD [18]. The solids used for this analysis
are separated from the wastewater liquid phase during primary clarification step (highlighted in red).

50

5.2 Experimental Specific Methodology

5.2.1 Collection of Sludge Samples

Sludge samples were only collected from JI WWTP due significantly longer hydraulic
residence time of the conveyance at SS WWTP. Aliquots were collected by POTW staff once
every 4 hours and composited over a 24-hour period using sterile 50 mL falcon tubes. In total, 6
grab samples were performed for each sample composite. Composites are stored 4°C, until inperson pick-up, and delivery on-ice. Once received in the lab, samples are stored at 4°C until
they were processed within 24 hours. In total, 25 sludge samples collected weekly from August
25, 2021, to February 23, 2022, were used in this analysis.

5.2.2 Processing Sludge Samples
40 mL of sludge solids were dewatered by centrifugation at 124,000 g-force for 30
minutes at 4°C, and the supernatant is disposed of in bleach. Approximately 0.075 grams
dewatered solids are removed as required for nucleic acid extraction, and the remaining solids
are used to calculate the dry weight of the dewatered solids. The dry weight of the sample was
recorded by measuring the weight of each dewatered-solids sample before and after heating at
75°C for at least 24 hours.

5.2.3 RNA Extraction of Sludge Samples
Approximately 0.075 g dewatered solids were suspended in DNA/RNA shield (Zymo
Research, CA) spiked with approximately 100,000 copies (1.5 μL) BCoV (Calf-guard Cattle
Vaccine, PBS Animal Health, OH). Resuspended samples were stored at -80°C (up to 24 hours)
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to increase RNA extraction yield until the nucleic acid extraction. Samples were allowed to
completely thaw on ice before bead beating for 2.5 minutes, resting on ice, and repeating before
loading into the King Fisher instrument, following the same extraction procedures as the JI
influent described in Chapter 2.2.4.

5.2.5 Data Analysis
This analysis compared all 25 sludge samples to 25 influent samples paired by date from
JI. SARS-CoV-2 concentration per capita (copies per person) in suspended solids (𝐶𝑠𝑜𝑙𝑖𝑑𝑠 ) can
be approximated using Equation 6. Where 𝐶𝑑𝑟𝑦 is the copies per gram of solids per dry weight of
our 24-hour composite sample, Q is average daily flow in liters (L) of influent, T is the daily
average total solids of the sludge in grams per liter (g/L), and P is the population of JI sewershed
(470,000 people).

𝐶𝑠𝑜𝑙𝑖𝑑𝑠 =

𝐶𝑑𝑟𝑦 ∗ 𝑄
𝑇∗𝑃

(6)

SARS-CoV-2 per of both sludge and influent were compared. Because the unit for sludge
concentration per capita is in copies per gram of solids, and the unit for influent is in copies per
liter of wastewater, RT-ddPCR droplet data was also compared since there is no true conversion
between liters and grams. Paired- t-tests were performed to determine if the primary settles solids
in sludge have a significant impact on SARS-CoV-2 concentration when comparing to
wastewater influent, and nonparametric Kendall’s tau was used to test if either method had a
better correlation between the clinical case rate confirmed in the JI sewershed and the SARSCoV-2 concentration detected from the sample.
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5.3 Results and Discussion

SARS-CoV-2 concentrations per capita in matched sludge and influent samples were
positively and significantly correlated (Kendall’s tau, p < 0.005). When comparing both the
detected RT-ddPCR positive droplets, and the SARS-CoV-2 concentration per capita, sludge
samples were significantly higher than in the influent samples from the same date (Paired t-test,
p < 0.005). Quantifying SARS-CoV-2 concentration from sludge produces up to two orders of
magnitude higher average concentration (Figure 19) than wastewater influent, indicating that
recovery may be better when comparing the solid versus liquid portion of wastewater.

Measurement
Mean
SD
Median
IQR

Sludge

Influent

4.69E+13 3.49E+11
4.76E+13 1.75E+12
3.37E+13 3.20E+11
2.84E+13 6.87E+11

Measurement
Mean
SD
Median
IQR

Sludge
220
185
169
204

Influent
126
162
66
111

Figure 19. Box plot of the total per capita SARS-CoV-2 concentration (left) and N1/N2 droplets detected by
RT-ddPCR (right) in the sludge (orange) and influent (yellow) data sets (n = 25).
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This conclusion agrees with previously published literature that have concluded both
SARS-CoV-2 and PMMoV RNA are enriched in the solid fraction of wastewater [85][89][90].
While this was a relatively small dataset, two influent samples were below LOQ, with one falling
below LOD. No sludge samples were below the LOQ. In addition, the droplet detection of N1
and N2 in sludge is on average double that of its influent counterpart (Figure 19). This data
suggests that quantification of RNA from sludge is more sensitive when concentrations are low,
and extraction of SARS-CoV-2 RNA from sludge can be used when community levels are so
low that they may go undetected.

Both sludge and influent SARS-CoV-2 concentration per capita were positively and
significantly correlated to the detected clinical cases within the JI sewershed (Kendall’s tau, p <
0.005), with influent having a slightly better linear relationship (Figure 20).

Figure 20. Kendall’s tau correlation of SARS-CoV-2 concentration per capita to number of clinical cases within
the JI sewershed extracted from influent (yellow) and sludge (orange) samples.
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While it is important to confirm sludge and influent are reliable methods for monitoring
COVID-19, as mentioned in Chapter 4, COVID-19 case rate data is not completely reliable for
monitoring prevalence due to under-reporting and other clinical testing data biases [57]. It is
more important for wastewater surveillance to capture COVID-19 infection trends, such as rapid
increases. Shifts in trends were adequately represented in sludge (Figure 21).

Figure 21. SARS-CoV-2 concentration per capita, and two-day moving average extracted from influent (yellow) and
sludge (orange) samples plotted by the clinical case rate of the JI sewershed (blue).
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Chapter 6. Conclusions and Future Work

This project investigated various factors that may diminish or improve the capability of
wastewater surveillance as a public health aid for the COVID-19 epidemic. The results showed
that laboratory methods can be used to increase the sensitivity of SARS-CoV-2 detection, such
as automated magnetic-bead-based RNA extraction. That monitoring COVID-19 variants
through RT-ddPCR analysis can be more representative than traditional public health metrics
such as clinical sequencing. While there are numerous wastewater parameters that can impact
SARS-CoV-2 persistence and detection, warm temperatures were the only parameter in this
study found to have a measurable impact within the residence time of an average sewer network.
And, that analyzing primary solids within wastewater instead of influent may double the
sensitivity of SARS-CoV-2 detection. Overall, this study further confirms what laboratories
across the world have already hypothesized and demonstrated; that wastewater surveillance is a
reliable metric for monitoring COVID-19 infection trends within a specific community
[15][17][45][70][86][89][90][91].

As we see COVID-19 declining and evolving, we can use the study of SARS-CoV-2
wastewater surveillance to help standardize laboratory techniques, and better understand how it
can be used for future applications, such as under-reported, new, or evolving viruses. When
compared to other public health tools, wastewater surveillance noninvasively and
comprehensively tracks infectious disease spread and resistance throughout a community in a
cost- and supply-effective manner. Wastewater surveillance was able to detect mutations and
emerging variants prior to clinical sequencing data in various communities across Wisconsin.
Outside of infectious disease prevalence, wastewater surveillance could use used to track a wide
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array of things such as drug and pharmaceutical use, antimicrobial resistance, and chemical
exposure [91]. Validation of using wastewater surveillance to track COVID-19 would be a step
in the right direction for other implications of wastewater surveillance to take off. Based the
positive results our lab has observed from SARS-CoV-2 wastewater surveillance, we have
already began working with Wisconsin DHS to monitor Influenza A and Influenza B, and
antimicrobial resistance in Wisconsin. The results of this study should prove useful in the
expansion of labs our wastewater surveillance projects, in addition to other research laboratories,
municipalities, public health officials, and policy makers who are seeking to monitor specific
viral, biological, or chemical targets in a noninvasive, comprehensive, and cost-effective manner.
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APPENDICIES

Appendix 1. Supplemental Tables and Figures for Chapter 4
Supplemental Table 1: Estimated travel times accounting for pipe diversions.
Plant
Wet Conditions*
Wet no Diversion
Ave Conditions
Dry Conditions
JI
5.25
4.68
7.45
11.36
SS
13.17
12.88
22.16
63.45
*Pipe diversions account for a 50% decrease in JI acreage and 10% increase in SS acreage

Supplemental Figure 1: The Daily Average Flow measurements (MGD) matching the date of sample
collection in SS (top) and JI (bottom) during warmest (left) and coolest (right) months.
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Appendix 2. Estimated Decay Rates Based of Negligible Travel Time Decay

The first-order decay rate constant (k) was estimated in R-studio (version 1.4.1103) from
linear regression using equations S1. Where 𝐶𝑗 and 𝐶𝑠 are the concentrations of GC/clinical caserate in the wastewater at 7.5 hours (JI), and 22 hours (SS), respectively, and k is the decay rate
constant.
𝐶

ln (𝐶𝑠 ) = −𝑘 × 𝑡

(S1)

𝑗

Supplemental Table 2: Estimated decay rates (k/day) of SARS-CoV-2 gram copies (GC) per clinical case per
day in wastewater in various flow conditions.
Flow Condition
k (GC/day)

Average

-0.001

Maximum

-0.0004

Minimum

-0.006

Statistics for liner regression of dataset include; residual standard error: 0.663 on 93 degrees of freedom, multiple Rsquared: 0.3271, adjusted R-squared: 0.3199, F-statistic: 45.21 on 1 and 93 degrees of freedom, p-value: 1.411e-09.
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Appendix 3. Equation of Best-fit for Case Adjusted SARS-CoV-2 Versus Temperature
Case adjusted SARS-CoV-2 concentration (million copies per case) (𝐶𝑐𝑝 ) throughout
different temperatures ranges measured in JI and SS was estimated in R-studio (version
1.4.1103) using equation S2 based on the line of best-fit. Warm and cold months were not
broken down into separate data sets due to small numbers of observations.

𝐶𝑐𝑝 = 𝑒 𝛽0 +𝛽1𝑇

(S2)

Where T is the average temperature in each specific instance, and 𝛽0 represents the
intercept of the regression line when T = 0, and 𝛽1 represents the slope of the regression line.

Supplemental Figure 2: Total average case adjusted SARS-CoV-2 concentration (million copies per case) in
SS. Line of best fit representing SARS-CoV-2 decay with increasing temperature illustrated in blue. Relevant
statistics in top right corner.
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Supplemental Figure 3: Total average case adjusted SARS-CoV-2 concentration (million copies per case) in
JI. Line of best fit representing SARS-CoV-2 decay with increasing temperature illustrated in blue. Relevant
statistics in top right corner.
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